Global Chenodeoxycholic Acid Market Outlook 2016-2021
- GEN974630
- 94 Pages
- December 2016
- Pharmaceuticals
Chenodeoxycholic acid and cholic acid are the two primary bile acids in humans. Some other mammals have muricholic acid or deoxycholic acid rather than chenodeoxycholic acid.
Chenodeoxycholic acid is synthesized in the liver from cholesterol by a process which involves several enzymatic steps. Like other bile acids, it can be conjugated in the liver with taurine or glycine, forming taurochenodeoxycholate or glycochenodeoxycholate. Conjugation results in a lower pKa. This means the conjugated bile acids are ionized at the usual pH in the intestine and will stay in the gastrointestinal tract until reaching the ileum where most will be reabsorbed. Bile acids form micelles which facilitate lipid digestion. After absorption, they are taken up by the liver and resecreted, so undergoing an enterohepatic circulation. Unabsorbed chenodeoxycholic acid can be metabolised by bacteria in the colon to form the secondary bile acid known as lithocholic acid.
The global chenodeoxycholic acid production, which measures output worldwide, was expected to reach xx tons in 2016 with an increase of xx% from its year-earlier level. The global chenodeoxycholic acid market size is estimated to grow from USD xx million in 2011 to USD xx million by 2016, at an estimated CAGR of xx% between 2011 and 2016. With regards to this, key players of chenodeoxycholic acid industry are expected to find potential opportunities in this market.
The global chenodeoxycholic acid market report profiles some of the key technological developments in the recent times. It also profiles some of the leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global chenodeoxycholic acid market are ICE, Tianli Biochemical, Zhongshan Belling, Suzhou Tianlu, Hengchanglong, etc.
The global chenodeoxycholic acid industry is relatively concentrated, with the market share of top 5 chenodeoxycholic acid producers at xx%.
Part 1. Scope of Report
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered
Part 2. Introduction
2.1 Definition
2.2 Therapeutic applications
2.2.1 Gallstones Treatment
2.2.2 Ursodeoxycholic Acid
2.2.3 Other Uses
Part.3 Market Scenario
3.1 Current Scenario
Part 4. Manufacture
4.1 Manufacturing Process
4.2 Manufacturing Costs
Part 5. Worldwide Key Vendors
5.1 ICE (Italy)
5.1.1 Business Overview
5.1.2 Products Offered
5.1.3 Business Performance
5.2 Hengchanglong (China)
5.2.1 Business Overview
5.2.2 Products Offered
5.2.3 Business Performance
5.3 Suzhou Tianlu (China)
5.3.1 Business Overview
5.3.2 Products Offered
5.3.3 Business Performance
5.4 Zhongshan Belling (China)
5.4.1 Business Overview
5.4.2 Products Offered
5.4.3 Business Performance
5.5 Anhui Chem-Bright (China)
5.5.1 Business Overview
5.5.2 Products Offered
5.5.3 Business Performance
5.6 Yungang Biotechnology (China)
5.6.1 Business Overview
5.6.2 Products Offered
5.6.3 Business Performance
5.7 Tianli Biochemical (China)
5.7.1 Business Overview
5.7.2 Products Offered
5.7.3 Business Performance
5.8 Daewoong China (China)
5.8.1 Business Overview
5.8.2 Products Offered
5.8.3 Business Performance
Part 6. Market Overview
6.1 Global Production Volume 2011-2016
6.2 Production Volume by Region 2011-2016
6.2.1 China
6.2.3 EMEA
6.2.4 Asia-Pacific
6.3 Global Production Value 2011-2016
6.4 Production Value by Region
6.4.1 China
6.4.3 EMEA
6.4.4 Asia-Pacific
Part 7. Consumption Pattern
7.1 Regional Consumption
7.1.1 China
7.1.3 EMEA
7.1.4 Asia-Pacific
7.2 Global Consumption by Application
7.3 Chinese Consumption by Application
Part 8. Market Forecast
8.1 Market Size Forecast
8.1.1 Market Size by Volume (Tons)
8.1.2 Market Size by Value (M USD)
8.2 Regional Consumption Forecast
8.2.1 China
8.2.3 EMEA
8.2.4 Asia-Pacific
8.3 Consumption Forecast by Application
Part 9. Market Dynamics
9.1 Market Drivers
9.2 Market Constraints
9.2.1 Entry Barriers
9.2.2 Exchange Rate
9.2.3 Rising Costs
9.2 Market Strategies
9.3 Key Events
Part 10. Investment Feasibility
10.1 Global Economic Highlight 2015
10.2 Recent Developments
10.3 The Updated Forecast
10.3.1 Advanced Economies
10.3.2 Emerging Market and Developing Economies
10.4 China Outlook 2016
10.5 Investment in China
10.5.1 Outlook on investment
10.5.2 Growth opportunities
10.5.3 Policy Trends
10.5.4 Conclusions
10.6 Feasibility of New Project
10.6.1 Basis and Presumptions
10.6.2 New Project in China
Disclaimer
Analyst(s) CertificationFigure Global Production 2011-2016
Figure Global Production Value (M USD) 2011-2016
Figure Top 10 Players Revenue Share 2015
Figure Regional Production 2015
Figure Regional Production Value (M USD) 2015
Figure Global Consumption by End Market 2015
Figure Chenodeoxycholic Acid Product
Figure Supply Chain Structure of Chenodeoxycholic Acid
Table Raw Materials Used for Chenodeoxycholic Acid Production
Table Traders & Distributors of Chenodeoxycholic Acid
Table Key Customers of Chenodeoxycholic Acid
Figure Chenodeoxycholic Acid Manufacturing Process Flow
Figure Chenodeoxycholic Acid Production Cost Structure
Figure Global Chenodeoxycholic Acid Market, Growth Rate
Table Global Key Vendors Production 2011-2016
Table Global Key Vendors Production Market Share 2011-2016
Figure Global Production, Capacity Utilization 2011-2016
Figure Top 10 Companies Market Share Trends
Table Global Top 10 Vendors Production 2011
Table Global Top 10 Vendors Production 2012
Table Global Top 10 Vendors Production 2013
Table Global Top 10 Vendors Production 2014
Table Global Top 10 Vendors Production 2015
Table Global Top 10 Vendors Production 2016
Figure Global Chenodeoxycholic Acid Market (M USD), Growth Rate & CAGR
Table Global Key Vendors Production Value (M USD) 2011-2016
Table Global Key Vendors Production Value Market Share 2011-2016
Figure Top 10 Player Market Share Trends
Table Global Top 10 Vendors Production Value (M USD) 2011
Table Global Top 10 Vendors Production Value (M USD) 2012
Table Global Top 10 Vendors Production Value (M USD) 2013
Table Global Top 10 Vendors Production Value (M USD) 2014
Table Global Top 10 Vendors Production Value (M USD) 2015
Table Global Top 10 Vendors Production Value (M USD) 2016
Figure Prices of Major Players 2016
Figure Gross Margin of Major Players 2016
Table Types of Chenodeoxycholic Acid
Figure Global Production Market Share of Chenodeoxycholic Acid by Types in 2015
Table Type 1 Chenodeoxycholic Acid Production 2011-2016
Table Type 1 Chenodeoxycholic Acid Price Trends 2011-2016
Table Major Manufacturers of Type 1 Chenodeoxycholic Acid
Table Type 2 Chenodeoxycholic Acid Production 2011-2016
Table Type 2 Chenodeoxycholic Acid Price Trends 2011-2016
Table Major Manufacturers of Type 2 Chenodeoxycholic Acid
Table Type 3 Chenodeoxycholic Acid Production 2011-2016
Table Type 3 Chenodeoxycholic Acid Price Trends 2011-2016
Table Major Manufacturers of Type 3 Chenodeoxycholic Acid
Figure Global Chenodeoxycholic Acid Market by Key Customer Segments 2015
Table Chenodeoxycholic Acid Consumed for Customer Segment 1
Table Key Customers of Chenodeoxycholic Acid
Table Chenodeoxycholic Acid Consumed for Customer Segment 2
Table Key Customers of Chenodeoxycholic Acid
Table Chenodeoxycholic Acid Consumed for Customer Segment 3
Table Key Customers of Chenodeoxycholic Acid
Figure Global Chenodeoxycholic Acid Market Segmentation by Geography 2015
Figure North America Chenodeoxycholic Acid Capacity & Production 2011-2016
Figure North America Chenodeoxycholic Acid Revenue (M USD) 2011-2016
Figure North America Chenodeoxycholic Acid Price & Margin 2011-2016
Table North America Chenodeoxycholic Acid Trade Balance
Figure North America Chenodeoxycholic Acid Self-sufficiency
Figure EMEA Chenodeoxycholic Acid Capacity & Production 2011-2016
Figure EMEA Chenodeoxycholic Acid Revenue (M USD) 2011-2016
Figure EMEA Chenodeoxycholic Acid Price & Margin 2011-2016
Table EMEA Chenodeoxycholic Acid Trade Balance
Figure EMEA Chenodeoxycholic Acid Self-sufficiency
Figure Asia Pacific Chenodeoxycholic Acid Capacity & Production 2011-2016
Figure Asia Pacific Chenodeoxycholic Acid Revenue (M USD) 2011-2016
Figure Asia Pacific Chenodeoxycholic Acid Price & Margin 2011-2016
Table Asia Pacific Chenodeoxycholic Acid Trade Balance
Figure Asia Pacific Chenodeoxycholic Acid Self-sufficiency
Figure Global Production Volume Forecast 2016-2021
Table Global Production Volume 2016-2021
Table Global Production Volume Share 2016-2021
Figure North America Chenodeoxycholic Acid Production Volume Forecast
Figure Global Production Value (M USD) 2016-2021
Table Global Production Value (M USD) 2016-2021
Table Global Production Value Share 2016-2021
Figure North America Chenodeoxycholic Acid Production Value (M USD) Forecast
Figure Regional Consumption 2021
Table Consumption Volume by Region 2016-2021
Table Consumption Volume Share by Region 2016-2021
Figure North America Consumption 2016-2021
Figure Consumption by Key Customer Segments 2021
Table Global Chenodeoxycholic Acid Market by Customer Segments 2016-2021 (Volume)
Table Global Chenodeoxycholic Acid Market by Customer Segments 2016-2021 (Share)
Figure Consumption by Types 2021
Table Global Consumption Volume by Types 2016-2021
Table Global Consumption Volume Share by Types 2016-2021
Table Financial Performance 2011-2016
Figure Market Share Trend 2011-2016
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
